MALT1 and Alzheimer disease: Future studies with integrated CSF multi-omics (simultaneous metabolomic and MALT1 protein measurements in the same individuals) and refined functional annotation (eQTL, chromatin interaction data and colocalization analyses) will be required to directly test whether the leucine/creatine–AD relationship is mediated through MALT1-related pathways.